Thomas M. Maddox, MD, SM1-3

home / authors / thomas-m-maddox-md-sm1-3

Articles

Medication nonadherence and adverse outcomes in CAD patients

P. Michael Ho, MD, PhD1-3;David J. Magid, MD, MPH2,3;Susan M. Shetterly, MS3;Kari L. Olson, PharmD, BCPS2,4;Thomas M. Maddox, MD, SM1-3;Pamela N. Peterson, MD, MSPH2,3,5;Frederick A. Masoudi, MD

February 18th 2009

Nonadherence to beta blockers, statins, or angiotensin-converting enzyme inhibitors is common (21%-29%) among patients with coronary artery disease (CAD). Patients who do not adhere to their medication regimens are at increased risk of mortality, cardiovascular hospitalizations, and revascularization procedures; thus, medication nonadherence should be a target for quality improvement interventions to maximize the outcomes of CAD patients.